Table 1.

Suppression of pbl3 mutant mesoderm phenotype

GenotypeEve-positive hemisegmentss.d.n
pbl3/pbl3 1.7 1.7 128 
PblA-HA; pbl3/pbl3 18.6 1.7 98 
PblΔBRCT; pbl3/pbl3 8.3 4.2 69 
PblDH-PH; pbl3/pbl3 8.9 2.9 102 
PblDH-PH_V531D; pbl3/pbl3 2.8 2.2 101 
PblΔN-term; pbl3/pbl3 3.3 2.4 123 
PblDH; pbl3/pbl3 2.4 2.2 106 
PblΔC-term; pbl3/pbl3 7.7 2.9 88 
GenotypeEve-positive hemisegmentss.d.n
pbl3/pbl3 1.7 1.7 128 
PblA-HA; pbl3/pbl3 18.6 1.7 98 
PblΔBRCT; pbl3/pbl3 8.3 4.2 69 
PblDH-PH; pbl3/pbl3 8.9 2.9 102 
PblDH-PH_V531D; pbl3/pbl3 2.8 2.2 101 
PblΔN-term; pbl3/pbl3 3.3 2.4 123 
PblDH; pbl3/pbl3 2.4 2.2 106 
PblΔC-term; pbl3/pbl3 7.7 2.9 88 

Mean values and standard deviations (s.d.) of the number of Eve-positive hemisegments are shown for pbl3 homozygous embryos expressing Pbl constructs as indicated (n=number of embryos examined). Fig. 2J shows a graph of the relative proportions.

Close Modal

or Create an Account

Close Modal
Close Modal